✦ LIBER ✦

PCV93 COST-EFFECTIVENESS ANALYSIS OF EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE STATIN DOSE: ANALYSIS OF THE INFORCE STUDY IN THE UK

✍ Scribed by JP Reckless; GM Davies; K Tunceli; XH Hu; P Brudi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Projected Cost-Effectiveness of Ezetimib

✍ John Reckless; Glenn Davies; Kaan Tunceli; X. Henry Hu; Philippe Brudi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Lipid-altering efficacy of ezetimibe/sim

✍ J. P. D. Reckless; P. Henry; T. Pomykaj; S. T. Lim; R. Massaad; K. Vandormael; A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

PCV71 COST-EFFECTIVENESS OF ROSUVASTATIN

✍ PS Miller; A Davies; M Marotti 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

[4] EZETIMIBE/SIMVASTATIN COMPARED WITH

✍ M. Averna; A. Zaninelli; C. Le Grazie; G.F. Gensini 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 109 KB

PCV18 COST OF ACHIEVING LDL REDUCTION AM

✍ YS Punekar; C O'Regan; P Harvey; T McCormack 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

LIPID-ALTERING EFFICACY OF EZETIMIBE/SIM

✍ Brudi, P.; Reckless, J.; Henry, P.; Pomykaj, T.; Lim, S.; Massaad, R.; Vandormae 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 193 KB